| Hans-Günter Meyer-Thompson | Hersteller
FDA Inches Closer to OTC Narcan—at the Expense of Generic Naloxone
FDA Inches Closer to OTC Narcan—at the Expense of Generic Naloxone
Advisors to the Food and Drug Administration have voted unanimously in support of making a naloxone product available without requiring a prescription, as the pharmaceutical company manufacturing that product doubled down on needle stigma. (Filter, USA, 15.02.2023)